AstraZeneca PLC has signed an exclusive framework agreement with China's Shenzhen Kangtai Biological Products to supply its COVID-19 vaccine ...
BEIJING: AstraZeneca has signed an exclusive framework agreement with China's Shenzhen Kangtai Biological Products to supply its COVID-19 vaccine candidate in mainland China, the British pharmaceutical giant said on Thursday .
To meet market demand in China, Shenzhen Kangtai is obliged to make sure it has an annual production capacity of at least 100 million doses of the experimental shot AZD1222 – which AstraZeneca co-developed with researchers at Oxford University – by the end of this year, and a capacity of at least 200 million doses by the end of next year, AstraZeneca said in a statement on the Chinese social media site WeChat.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Moderna says discussing supply deals with countries for Covid-19 vaccineBANGALORE (REUTERS) - Moderna said on Wednesday (Aug 5) it has started talks with several countries for supply agreements for its experimental coronavirus vaccine and has received about US$400 million (S$548 million) in deposits for potential supply.. Read more at straitstimes.com.
Read more »
Moderna says discussing supply deals with countries for COVID-19 vaccineModerna Inc said on Wednesday it has started talks with several countries for supply agreements for its experimental coronavirus vaccine and has ...
Read more »
Novavax signs COVID-19 vaccine supply deal with India's Serum InstituteNovavax Inc said on Wednesday it has entered a supply and license agreement with the Serum Institute of India for the development and ...
Read more »
Malaysia in talks with China over potential MOU for early access to COVID-19 vaccine: Science and technology ministerKUALA LUMPUR: Malaysia is in talks with China over a potential Memorandum of Understanding to ensure access to the COVID-19 vaccine when it is ...
Read more »
Pfizer announces deal with Canada for experimental COVID-19 vaccineOTTAWA: Pharmaceutical giant Pfizer and German biotech firm BioNTech on Wednesday (Aug 5) said they had signed a deal to supply Canada with an ...
Read more »
Human trials of COVID-19 vaccine set to begin in IndonesiaHuman trials on a potential coronavirus vaccine are due to start in Indonesia next week as part of a collaboration between state-owned ...
Read more »